These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9453660)

  • 1. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.
    Darling P; Chan M; Cox AD; Sokol PA
    Infect Immun; 1998 Feb; 66(2):874-7. PubMed ID: 9453660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia.
    Sokol PA
    J Clin Microbiol; 1986 Mar; 23(3):560-2. PubMed ID: 2937804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ornibactin production and transport properties in strains of Burkholderia vietnamiensis and Burkholderia cepacia (formerly Pseudomonas cepacia).
    Meyer JM; Van VT; Stintzi A; Berge O; Winkelmann G
    Biometals; 1995 Oct; 8(4):309-17. PubMed ID: 7580051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ornibactin biosynthesis and N-acyl-L-homoserine lactone production by CepR in Burkholderia cepacia.
    Lewenza S; Sokol PA
    J Bacteriol; 2001 Apr; 183(7):2212-8. PubMed ID: 11244059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-regulated salicylate synthesis by Pseudomonas spp.
    Visca P; Ciervo A; Sanfilippo V; Orsi N
    J Gen Microbiol; 1993 Sep; 139(9):1995-2001. PubMed ID: 7504066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.
    Mahenthiralingam E; Campbell ME; Henry DA; Speert DP
    J Clin Microbiol; 1996 Dec; 34(12):2914-20. PubMed ID: 8940422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron acquisition mechanisms of the Burkholderia cepacia complex.
    Thomas MS
    Biometals; 2007 Jun; 20(3-4):431-52. PubMed ID: 17295049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.
    Segonds C; Bingen E; Couetdic G; Mathy S; Brahimi N; Marty N; Plesiat P; Michel-Briand Y; Chabanon G
    J Clin Microbiol; 1997 Aug; 35(8):2055-60. PubMed ID: 9230381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom.
    Clode FE; Kaufmann ME; Malnick H; Pitt TL
    J Clin Microbiol; 2000 May; 38(5):1763-6. PubMed ID: 10790095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing of Pseudomonas aeruginosa, Pseudomonas aureofaciens, Burkholderia (Pseudomonas) cepacia, Pseudomonas fluorescens, and Pseudomonas putida with the ferripyochelin receptor A gene and the synthesis of pyochelin in Pseudomonas aureofaciens, Pseudomonas fluorescens, and Pseudomonas putida.
    Castignetti D
    Curr Microbiol; 1997 Apr; 34(4):250-7. PubMed ID: 9058547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase.
    Sokol PA; Darling P; Woods DE; Mahenthiralingam E; Kooi C
    Infect Immun; 1999 Sep; 67(9):4443-55. PubMed ID: 10456885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.
    Coenye T; Mahenthiralingam E; Henry D; LiPuma JJ; Laevens S; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Jul; 51(Pt 4):1481-1490. PubMed ID: 11491349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.
    Barth AL; Pitt TL
    J Clin Microbiol; 1995 Aug; 33(8):2192-4. PubMed ID: 7559977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.
    Okazaki M; Watanabe T; Morita K; Higurashi Y; Araki K; Shukuya N; Baba S; Watanabe N; Egami T; Furuya N; Kanamori M; Shimazaki S; Uchimura H
    J Clin Microbiol; 1999 Dec; 37(12):3809-14. PubMed ID: 10565889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of transmission of Burkholderia cepacia isolates in an intrahospital by randomly amplified polymorphic DNA-PCR method].
    Okazaki M; Morita K; Kochi N; Araki K; Yoshizawa M; Wada H; Shibata M; Watanabe N; Egami T; Furuya N; Kanamori M; Shimazaki S; Uchimura H
    Kansenshogaku Zasshi; 1998 Jul; 72(7):688-93. PubMed ID: 9745217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From a total synthesis of cepabactin and its 3:1 ferric complex to the isolation of a 1:1:1 mixed complex between iron (III), cepabactin and pyochelin.
    Klumpp C; Burger A; Mislin GL; Abdallah MA
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1721-4. PubMed ID: 15745828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
    Speert DP; Henry D; Vandamme P; Corey M; Mahenthiralingam E
    Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic.
    Drevinek P; Vosahlikova S; Cinek O; Vavrova V; Bartosova J; Pohunek P; Mahenthiralingam E
    J Med Microbiol; 2005 Jul; 54(Pt 7):655-659. PubMed ID: 15947430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
    Simpson IN; Finlay J; Winstanley DJ; Dewhurst N; Nelson JW; Butler SL; Govan JR
    J Antimicrob Chemother; 1994 Sep; 34(3):353-61. PubMed ID: 7530242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.